Yoon et al. demonstrated that EC-18 inhibited the activity of STAT6, a transcriptional activator of IL-4 expression, in monocyte and T lymphocyte cell lines, and lowered the levels of IL-4 and IgE in mice with DNCB-induced atopy-like dermatitis [22]. This evidence concerns the gene IGHE and skin disorder.